AMGN vs SOLV
By Alex · Tickerpine
Amgen Inc. vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | SOLV |
|---|---|---|
| Price | $358.33 | $79.53 |
| Market cap | $193.39B | $13.77B |
| P/E ratio | 24.9 | 9.7 |
| ROE | 101.32% | 34.79% |
| Profit margin | 20.96% | 17.33% |
| Revenue growth | 5.80% | -3.00% |
| Dividend yield | 2.81% | — |
| Beta | 0.42 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs SOLV in plain English
- AMGN is the bigger company — about 14.0× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 9.7 vs 24.9).
- AMGN earns a higher return on equity (101% vs 35%).
- AMGN is growing revenue faster (6% vs -3%).
- AMGN pays a dividend (2.81%) while the other effectively doesn't.
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.